Cell study · normal human keratinocytes
LL-37 raised TLR9 and interferon output in human skin cells
Checked against the paper Cell studyPublished by PepVault
The takeaway
In human skin cells, LL-37 made them react more strongly to DNA with an interferon immune response, a pattern also seen in psoriasis skin.
- Kind
- Cell study
- Studied in
- Normal human keratinocytes
- Published
- 2012
- Journal
- J Invest Dermatol
What they tested
The team asked whether LL-37 lets skin cells react to DNA through TLR9 (Toll-like receptor 9), and whether this ties in with psoriasis.
How the study was done
A lab study that compared skin from psoriasis lesions with normal skin, then exposed normal human keratinocytes (the main cells of the outer skin layer) grown in culture to LL-37, followed by TLR9 triggers such as CpG or genomic DNA.

What they found
In psoriasis lesions, human keratinocytes showed more TLR9, in the same areas where LL-37 levels were higher. In cultured normal human keratinocytes, LL-37 raised TLR9 levels, and cells primed with LL-37 then given CpG or genomic DNA made much more type I interferon (immune signaling proteins). Psoriasis lesions likewise held more interferon-beta than normal skin without LL-37. This response needed TLR9 but did not depend on LL-37 binding to the DNA.
What it doesn’t show
Most of the work was in cultured skin cells, and the skin comparisons show patterns rather than cause. LL-37 was not tested as a treatment in people or animals.
The paper
Morizane et al. Cathelicidin antimicrobial peptide LL-37 in psoriasis enables keratinocyte reactivity against TLR9 ligands. J Invest Dermatol. 2012.
The compound
More studies on LL-37
- LL-37 cream: bigger granulation gains in diabetic foot ulcersRandomized trial · people · 2023
- LL-37: no healing gain over placebo for venous leg ulcers overallRandomized trial · people · 2021
- LL-37 drove IL-1β and IL-18 release from human and murine macrophagesCell study · human and murine macrophages · 2013
- Every study on LL-37
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.